Sandoz is a generic division of and a member of the Novartis Group. In Bosnia and Hercegovina, we operate under the name of Lek Pharmaceuticals Representative Office, which it acquired in the meantime.

A leading global company in the market for generic and biosimilar drugs based in Holzkirchen. The division was founded in 2003, when Novartis merged all its generic drug companies under the name of Sandoz - a unique global brand with a long history. Since then, Sandoz has grown into one of the leading global companies in the generic drug market.

The main strength of our large portfolio is our position as a global leader in the segment of biosimilar drugs, advanced innovative drugs whose patents have expired, as well as antibiotics, which are also the foundation of the world's health systems.

Sandoz's position as one of the leading manufacturers of generic drugs allows us a continuous influx of quality, technologically demanding products and biosimilar drugs to the Bosnian market.